Skip to main content
Erschienen in: Breast Cancer Research 3/2011

01.06.2011 | Editorial

Spotlight on Geminin

verfasst von: Melvin L DePamphilis

Erschienen in: Breast Cancer Research | Ausgabe 3/2011

Einloggen, um Zugang zu erhalten

Abstract

In the previous issue of Breast Cancer Research, Gardner and co-workers describe a novel interaction between Geminin, a protein that prevents reinitiation of DNA replication, and Topoisomerase IIα (TopoIIα), an enzyme essential for removing catenated intertwines between sister chromatids. Geminin facilitates the action of TopoIIα, thereby promoting termination of DNA replication at the same time it inhibits initiation. In this manner, Geminin ensures that cells duplicate their genome once, but only once, each time they divide. Remarkably, either depletion of Geminin or over-expression of Geminin inhibits the action of TopoIIα, thereby making Geminin an excellent target for cancer chemotherapy.
Literatur
1.
Zurück zum Zitat Gardner L, Malik R, Shimizu Y, Mullins N, ElShamy WM: Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation leading to aneuploidy in human mammary epithelial cells. Breast Cancer Res. 2011, 13: R53-10.1186/bcr2884.CrossRefPubMedPubMedCentral Gardner L, Malik R, Shimizu Y, Mullins N, ElShamy WM: Geminin overexpression prevents the completion of topoisomerase IIα chromosome decatenation leading to aneuploidy in human mammary epithelial cells. Breast Cancer Res. 2011, 13: R53-10.1186/bcr2884.CrossRefPubMedPubMedCentral
2.
Zurück zum Zitat DePamphilis ML: DNA Replication and Human Disease. 2006, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press DePamphilis ML: DNA Replication and Human Disease. 2006, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory Press
3.
Zurück zum Zitat Lim JW, Hummert P, Mills JC, Kroll KL: Geminin cooperates with Polycomb to restrain multi-lineage commitment in the early embryo. Development. 2011, 138: 33-44. 10.1242/dev.059824.CrossRefPubMedPubMedCentral Lim JW, Hummert P, Mills JC, Kroll KL: Geminin cooperates with Polycomb to restrain multi-lineage commitment in the early embryo. Development. 2011, 138: 33-44. 10.1242/dev.059824.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Yellajoshyula D, Patterson ES, Elitt MS, Kroll KL: Geminin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hyperacetylated state. Proc Natl Acad Sci USA. 2011, 108: 3294-3299. 10.1073/pnas.1012053108.CrossRefPubMedPubMedCentral Yellajoshyula D, Patterson ES, Elitt MS, Kroll KL: Geminin promotes neural fate acquisition of embryonic stem cells by maintaining chromatin in an accessible and hyperacetylated state. Proc Natl Acad Sci USA. 2011, 108: 3294-3299. 10.1073/pnas.1012053108.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Miotto B, Struhl K: HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by Geminin. Mol Cell. 2010, 37: 57-66. 10.1016/j.molcel.2009.12.012.CrossRefPubMedPubMedCentral Miotto B, Struhl K: HBO1 histone acetylase activity is essential for DNA replication licensing and inhibited by Geminin. Mol Cell. 2010, 37: 57-66. 10.1016/j.molcel.2009.12.012.CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Falaschi A, Abdurashidova G, Biamonti G: DNA replication, development and cancer: a homeotic connection?. Crit Rev Biochem Mol Biol. 2010, 45: 14-22. 10.3109/10409230903365608.CrossRefPubMed Falaschi A, Abdurashidova G, Biamonti G: DNA replication, development and cancer: a homeotic connection?. Crit Rev Biochem Mol Biol. 2010, 45: 14-22. 10.3109/10409230903365608.CrossRefPubMed
7.
Zurück zum Zitat Lutzmann M, Mechali M: MCM9 binds Cdt1 and is required for the assembly of prereplication complexes. Mol Cell. 2008, 31: 190-200. 10.1016/j.molcel.2008.07.001.CrossRefPubMed Lutzmann M, Mechali M: MCM9 binds Cdt1 and is required for the assembly of prereplication complexes. Mol Cell. 2008, 31: 190-200. 10.1016/j.molcel.2008.07.001.CrossRefPubMed
8.
Zurück zum Zitat Haruki T, Shomori K, Hamamoto Y, Taniguchi Y, Nakamura H, Ito H: Geminin expression in small lung adenocarcinomas: implication of prognostic significance. Lung Cancer. 2011, 71: 356-362. 10.1016/j.lungcan.2010.06.013.CrossRefPubMed Haruki T, Shomori K, Hamamoto Y, Taniguchi Y, Nakamura H, Ito H: Geminin expression in small lung adenocarcinomas: implication of prognostic significance. Lung Cancer. 2011, 71: 356-362. 10.1016/j.lungcan.2010.06.013.CrossRefPubMed
9.
Zurück zum Zitat Zhu W, Depamphilis ML: Selective killing of cancer cells by suppression of geminin activity. Cancer Res. 2009, 69: 4870-4877. 10.1158/0008-5472.CAN-08-4559.CrossRefPubMedPubMedCentral Zhu W, Depamphilis ML: Selective killing of cancer cells by suppression of geminin activity. Cancer Res. 2009, 69: 4870-4877. 10.1158/0008-5472.CAN-08-4559.CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Lee J, Kim JA, Margolis RL, Fotedar R: Substrate degradation by the anaphase promoting complex occurs during mitotic slippage. Cell Cycle. 2010, 9: 1792-1801. 10.4161/cc.9.9.11519.CrossRefPubMedPubMedCentral Lee J, Kim JA, Margolis RL, Fotedar R: Substrate degradation by the anaphase promoting complex occurs during mitotic slippage. Cell Cycle. 2010, 9: 1792-1801. 10.4161/cc.9.9.11519.CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Nakuci E, Xu M, Pujana MA, Valls J, Elshamy WM: Geminin is bound to chromatin in G2/M phase to promote proper cytokinesis. Int J Biochem Cell Biol. 2006, 38: 1207-1220. 10.1016/j.biocel.2005.12.017.CrossRefPubMed Nakuci E, Xu M, Pujana MA, Valls J, Elshamy WM: Geminin is bound to chromatin in G2/M phase to promote proper cytokinesis. Int J Biochem Cell Biol. 2006, 38: 1207-1220. 10.1016/j.biocel.2005.12.017.CrossRefPubMed
12.
Zurück zum Zitat Schultz KM, Banisadr G, Lastra RO, McGuire T, Kessler JA, Miller RJ, McGarry TJ: Geminin-deficient neural stem cells exhibit normal cell division and normal neurogenesis. PLoS One. 2011, 6: e17736-10.1371/journal.pone.0017736.CrossRefPubMedPubMedCentral Schultz KM, Banisadr G, Lastra RO, McGuire T, Kessler JA, Miller RJ, McGarry TJ: Geminin-deficient neural stem cells exhibit normal cell division and normal neurogenesis. PLoS One. 2011, 6: e17736-10.1371/journal.pone.0017736.CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Shinnick KM, Eklund EA, McGarry TJ: Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice. J Clin Invest. 2010, 120: 4303-4315. 10.1172/JCI43556.CrossRefPubMedPubMedCentral Shinnick KM, Eklund EA, McGarry TJ: Geminin deletion from hematopoietic cells causes anemia and thrombocytosis in mice. J Clin Invest. 2010, 120: 4303-4315. 10.1172/JCI43556.CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Shreeram S, Sparks A, Lane DP, Blow JJ: Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene. 2002, 21: 6624-6632. 10.1038/sj.onc.1205910.CrossRefPubMedPubMedCentral Shreeram S, Sparks A, Lane DP, Blow JJ: Cell type-specific responses of human cells to inhibition of replication licensing. Oncogene. 2002, 21: 6624-6632. 10.1038/sj.onc.1205910.CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Nevis KR, Cordeiro-Stone M, Cook JG: Origin licensing and p53 status regulate Cdk2 activity during G(1). Cell Cycle. 2009, 8: 1952-1963. 10.4161/cc.8.12.8811.CrossRefPubMedPubMedCentral Nevis KR, Cordeiro-Stone M, Cook JG: Origin licensing and p53 status regulate Cdk2 activity during G(1). Cell Cycle. 2009, 8: 1952-1963. 10.4161/cc.8.12.8811.CrossRefPubMedPubMedCentral
Metadaten
Titel
Spotlight on Geminin
verfasst von
Melvin L DePamphilis
Publikationsdatum
01.06.2011
Verlag
BioMed Central
Erschienen in
Breast Cancer Research / Ausgabe 3/2011
Elektronische ISSN: 1465-542X
DOI
https://doi.org/10.1186/bcr2881

Weitere Artikel der Ausgabe 3/2011

Breast Cancer Research 3/2011 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.